GoHealthcare MSK Specialty Procedure Library™ | Lumbar Fusion Procedures
Anterior Lumbar Interbody Fusion (ALIF)
Developed by Pinky Maniri, Founder & Chief Executive Officer, GoHealthcare Practice Solutions
Clinical, coverage, medical necessity, prior authorization, documentation, coding, reimbursement, denial prevention, and operational guidance for MSK specialty teams.
This evergreen operational reference is designed for physicians, APPs, prior authorization teams, utilization management nurses, practice administrators, revenue cycle professionals, ASCs, hospitals, and healthcare executives. Verify current patient-specific payer, coding, clinical, and site-of-service requirements before use.
Up to 98%
Company-reported prior authorization approval performance in managed workflows. Results vary by payer, procedure, documentation quality, benefit design, and client implementation.
01
Coverage, Documentation & Operations
Evidence at a Glance
Anterior lumbar interbody fusion (ALIF) is an interbody arthrodesis performed through a front-of-the-abdomen (anterior retroperitoneal or transperitoneal) corridor, allowing a large lordotic implant to be placed with broad access to the disc space. Clinically, ALIF excels at restoring disc height, segmental lordosis, and sagittal alignment while providing indirect neural decompression. From a payer and operations standpoint it carries the same instability-centered medical-necessity scrutiny as other lumbar fusions, plus two distinctive dimensions: an access-surgeon workflow and an on-label pathway for rhBMP-2.
| Domain | Summary (verify against current payer policy & date of service) |
|---|---|
| Primary CPT® | 22558 (anterior interbody arthrodesis, single interspace, lumbar); +22585 each additional interspace |
| Medicare NCD | None specific to lumbar fusion. Coverage governed by MAC discretion, OPPS/ASC rules, and the 2-midnight rule. |
| Medicare LCD | MAC-specific LCDs exist (e.g., L37848 Lumbar Fusion; historical L33382). Require documented spondylolisthesis and/or instability; fusion for isolated degenerative disc disease is generally non-covered. Presacral/axial (AxiaLIF, 22586) is non-covered/investigational. |
| 2026 site-of-service | In the CY2026 OPPS/ASC Final Rule, CMS began phasing out the Inpatient-Only list with musculoskeletal codes (roughly 285 removed) and expanded the ASC Covered Procedures List. 22558 was among the anterior fusion codes CMS identified for this move; confirm its final OPPS Addendum B / ASC Addendum AA status at the date of service. Site of service is now a documented clinical determination. |
| Commercial PA | Required by essentially all commercial and Medicare Advantage plans. Frequently delegated to eviCore (CMM-609), Carelon, Cohere, Evolent, or TurningPoint. |
| Conservative therapy | Typically 6 weeks to 6 months of documented, failed, structured non-operative care (payer-dependent). |
| Imaging / instability | MRI or CT plus weight-bearing flexion/extension radiographs documenting anterolisthesis or dynamic translation when instability is the indication. Standing alignment films where sagittal balance is relevant. |
| Access considerations | Anterior retroperitoneal (or transperitoneal) approach; frequently uses an access/vascular exposure surgeon (co-surgeon, modifier 62). Great-vessel proximity is the principal approach risk. |
| Biologic note | rhBMP-2 (Infuse) is FDA-approved (on-label) for single-level ALIF with a specific cage - a key contrast with posterior interbody fusions where its use is off-label. Multi-level / off-label use remains payer-restricted. |
| Typical approval driver | A clear, imaging-correlated instability, listhesis, or reconstructive (sagittal/alignment) rationale tied to failed conservative care - not axial back pain alone. |
How to use this guide. The sections below move from clinical framing through coverage, medical necessity,
documentation, the device landscape, prior authorization workflow, denials and appeals, and coding fundamentals, followed by GoHealthcare operational insight, a case study, FAQs, and references. Every code and policy statement should be re-verified at the point of care.
02
Coverage, Documentation & Operations
Procedure Overview
ALIF reaches the lumbar disc space from the front of the body, avoiding the posterior paraspinal muscles and neural elements entirely. After the anterior anulus and disc are removed, a large interbody spacer packed with graft or a graft substitute is placed and the segment is stabilized - either by a stand-alone integrated cage (with built-in screws), an anterior plate, or supplemental posterior instrumentation placed in the same or a staged setting. Because the anterior corridor provides the broadest possible working window onto the disc, ALIF permits placement of a tall, lordotic implant that restores disc height and lumbar lordosis more powerfully than most posterior techniques.
The defining operational feature of ALIF is the approach. Access to the anterior lumbar spine requires mobilization around the great vessels (aorta, inferior vena cava, and iliac vessels), and many programs use a dedicated access or vascular exposure surgeon working alongside the spine surgeon. This shapes both the clinical risk profile (vascular injury, retrograde ejaculation in males) and the coding (co-surgeon reporting). ALIF is commonly performed at L5-S1 and L4-L5, where the anterior corridor is most favorable. The same anterior/anterolateral arthrodesis code also describes lateral and oblique interbody approaches (XLIF/LLIF and OLIF), which are covered in their own guides.
GOHEALTHCARE CLINICAL INSIGHTS - TWO STORIES IN EVERY ALIF RECORD
An ALIF authorization and claim must tell two coherent stories at once: the medical-necessity story (why this segment needs fusion) and the approach story (who performed the exposure and how the anterior corridor was managed). Practices that document only the first and leave the access-surgeon role implicit create avoidable co-surgery and reimbursement friction. Capture both from the outset: the structural indication, and the exposure surgeon's distinct operative role.
03
Coverage, Documentation & Operations
Relevant Anatomy (High-Level)
Only the anatomy needed to understand indications, documentation, coverage, and approach risk is summarized here; this guide is not a surgical atlas.
n Anterior lumbar disc space. The direct target of ALIF; broad anterior access allows a large lordotic interbody implant that restores disc height. n Great vessels. The aorta, inferior vena cava, and common iliac vessels overlie the anterior lumbar spine; their mobilization is the principal approach challenge and the reason an access/vascular surgeon is often involved. n Superior hypogastric plexus. The autonomic plexus anterior to the L5-S1 disc; injury can cause retrograde ejaculation in males, a specific ALIF consent and counseling point. n Segmental lordosis and sagittal balance. ALIF's ability to restore lordosis makes pelvic incidence, lumbar lordosis, and sagittal vertical axis relevant to both surgical planning and, at times, coverage. n Neural foramen. Restoring disc height provides indirect foraminal decompression without a posterior approach. n Retroperitoneal space and ureter. The retroperitoneal corridor and adjacent structures (ureter, sympathetic chain) inform contraindications such as prior retroperitoneal surgery.
04
Coverage, Documentation & Operations
Clinical Indications
ALIF is generally indicated when a structural, segmental problem produces concordant, disabling symptoms that have not responded to appropriate non-operative care, and where an anterior approach offers advantages in disc-height or lordosis restoration. Commonly accepted indications include:
n Degenerative spondylolisthesis with instability, particularly where anterior column support and lordosis restoration are goals. n Isthmic spondylolisthesis (often at L5-S1) with mechanical symptoms or radiculopathy. n Symptomatic degenerative disc disease at L5-S1 or L4-L5 with instability or as part of a reconstructive/alignment strategy (isolated discogenic pain alone remains payer-scrutinized). n Sagittal-plane deformity / flat-back where segmental lordosis restoration is a defined objective. n Adjacent-segment disease above or below a prior fusion. n Symptomatic pseudarthrosis (failed prior fusion) amenable to anterior column support. n Foraminal / lateral-recess compression addressable by indirect decompression through disc-height restoration, in the setting of instability.
WATCH-OUTS - WEAK OR NON-COVERED INDICATIONS
Isolated axial (mechanical) low back pain attributed to degenerative disc disease without instability, listhesis, or a defined reconstructive goal is the classic payer-scrutinized scenario. Discography as the sole justification for fusion is disfavored by most current policies. Presacral / axial interbody fusion (AxiaLIF; CPT 22586, 0195T, 0196T) is explicitly non-covered or investigational under several LCDs - confirm status before scheduling.
05
Coverage, Documentation & Operations
Patient Selection
Durable outcomes and clean authorizations both depend on selecting patients whose structural pathology, symptoms, modifiable risk profile, and vascular anatomy align with an anterior approach. Selection factors reviewers and surgeons weigh:
n Concordance between imaging findings, physical examination, and the patient's symptom pattern. n Documented failure of a structured, time-defined course of conservative care. n Vascular anatomy suitable for anterior access (vessel calcification, aortic bifurcation level relative to the target disc, prior thrombosis). n Absence of prohibitive prior retroperitoneal or abdominal surgery / adhesions. n Nicotine / tobacco status, with cessation counseling documented (a fusion inhibitor and an explicit criterion in several policies). n Bone quality: osteopenia or osteoporosis (for example, a DEXA T-score at or below -1.0) is an exclusion or caution in some payer guidelines and affects fixation strategy. n Body mass index, diabetic control, and other comorbidities affecting fusion and perioperative risk. n Male patients counseled regarding the risk of retrograde ejaculation; psychosocial screening where indicated.
06
Coverage, Documentation & Operations
Contraindications
Absolute / near-absolute
n Active local or systemic infection (unless the fusion is being performed to treat spinal infection). n Vascular anatomy precluding safe anterior access (e.g., severe atherosclerotic disease, unfavorable great-vessel configuration). n Prohibitive prior retroperitoneal / transperitoneal surgery with dense adhesions. n Medical instability precluding a major spine operation.
Relative / conditional
n Uncorrected severe osteoporosis (address before or concurrently with surgery). n Active nicotine use (many policies require documented cessation or counseling). n Morbid obesity or poorly controlled diabetes without optimization. n Solitary kidney or prior pelvic radiation (approach planning consideration). n Absence of a structural target - pain without instability, listhesis, or a defined reconstructive goal. n Male patients for whom retrograde-ejaculation risk is unacceptable without counseling.
07
Coverage, Documentation & Operations
Conservative Treatment Requirements
Nearly every payer conditions elective ALIF approval on documented, failed conservative care. Required duration varies commonly a minimum of 6 weeks for a clearly unstable, symptomatic listhesis, extending to 3-6 months for less acute presentations. The record should show structured care that was actually trialed:
n Activity modification and a supervised or prescribed physical therapy program, with dates, duration, and response. n Pharmacologic management appropriate to the diagnosis, with response documented. n Interventional procedures where clinically appropriate (for example, epidural steroid injection), with dates and outcomes. n Home exercise, bracing, or activity-based programs where relevant. n A clear statement that symptoms and functional impairment persisted despite the above.
GOHEALTHCARE PRIOR AUTHORIZATION INSIGHT - MAKE CONSERVATIVE CARE AUDIT-PROOF
The most avoidable fusion denial is a conservative-care timeline a reviewer cannot reconstruct. Do not write "failed conservative treatment." Capture the modality, the start and end dates, the provider, and the measured response for each trial. A dated, itemized conservative-care ledger converts a subjective claim into an objective, appealable fact and is the single highest-yield edit a practice can standardize - identical in value across ALIF, TLIF, and every other lumbar fusion.
08
Coverage, Documentation & Operations
Imaging Requirements
Imaging must establish the structural diagnosis, the dynamic component where instability is claimed, and - uniquely for ALIF - the vascular corridor. Expect payers and surgeons to require:
n MRI of the lumbar spine (or CT / CT-myelogram when MRI is contraindicated) demonstrating level-concordant pathology. n Weight-bearing flexion / extension radiographs when instability or spondylolisthesis is the indication, demonstrating anterolisthesis or dynamic translation. n Standing / upright and alignment films (including sagittal-balance views) where lordosis restoration or deformity is part of the rationale. n Vascular assessment of the anterior corridor (often via the MRI/CT) to characterize great-vessel position and calcification for approach planning. n A radiology report and, ideally, the treating surgeon's own correlation of imaging to symptoms and exam.
WATCH-OUTS - IMAGING PITFALLS THAT TRIGGER DENIALS
Submitting only supine MRI for an instability-based request is a common miss: dynamic instability may be invisible without upright flexion/extension views. A radiologist's description of canal or foraminal narrowing does not, by itself, establish instability or a reconstructive indication - the treating clinician must document the symptom-to-imaging correlation and the specific goal of the anterior approach.
09
Coverage, Documentation & Operations
Medical Necessity
Medical necessity for ALIF is built, not asserted. The record should demonstrate a logical chain from structural pathology to disabling, concordant symptoms, through failed conservative care, to a fusion whose specific goal (stabilization, indirect decompression, lordosis/alignment restoration) is stated. Elements reviewers weigh most heavily:
n A specific structural diagnosis (spondylolisthesis with grade; instability with the dynamic measurement; symptomatic L5-S1/L4-L5 pathology with the compressed level and root). n Concordant symptoms and objective examination findings. n Imaging that corroborates the diagnosis at the level to be fused. n A documented, dated, failed course of appropriate conservative care.
n A rationale for the anterior approach specifically (disc-height / lordosis restoration, anterior column support, indirect decompression, or access advantages). n An explicit medical-necessity statement authored by the operating surgeon.
GOHEALTHCARE LEADERSHIP PERSPECTIVE - THE INSTABILITY PIVOT APPLIES ANTERIORLY TOO
The central medical-necessity tension in lumbar fusion - whether fusion adds value over decompression alone applies to ALIF as it does to posterior techniques. Landmark trials (SLIP, Ghogawala 2016) support adding fusion for degenerative spondylolisthesis, while others (Forsth 2016; NORDSTEN-DS, Austevoll 2021) found decompression alone non-inferior in selected patients. Payers have absorbed this into their guidelines, which is why instability - not stenosis or axial pain alone - remains the pivot on which fusion approvals turn. ALIF adds a second, favorable dimension: where the clinical goal is genuine lordosis or sagittal-alignment restoration, the anterior approach has a defensible mechanical rationale. The operational lesson is to document the specific instability or reconstructive objective that places this patient in the benefit group, rather than arguing the literature in the chart.
10
Coverage, Documentation & Operations
Documentation Requirements
Use the following as a pre-submission checklist. Each item that is present, dated, and specific reduces the probability of a request for information, a peer-to-peer, or a denial.
n Chief complaint and symptom duration, with functional impact (e.g., ODI or documented activity limitation) n Pain characterization and distribution (axial vs. radicular vs. claudicant) n Focused neurological examination (motor, sensory, reflexes, provocative signs) n Specific structural diagnosis with level(s) and, for listhesis, Meyerding grade n MRI or CT findings correlated to the symptomatic level n Weight-bearing flexion/extension radiographs when instability is the indication n Standing / sagittal-alignment films where lordosis restoration is a goal n Itemized, dated conservative-care ledger with measured response n Nicotine/tobacco status and cessation counseling; bone-density status where relevant n Rationale for the anterior approach and, if applicable, retrograde-ejaculation counseling n Access/exposure-surgeon role documented (for co-surgery reporting) n Planned levels, standalone vs. supplemental fixation, interbody device, graft/biologic n Explicit surgeon medical-necessity statement and site-of-service rationale
11
Coverage, Documentation & Operations
Device Manufacturers & System Considerations
ALIF is device-intensive; the guide addresses the implant landscape at an operational level. Mention of specific manufacturers is for identification only and is not an endorsement.
Interbody spacers (ALIF cages)
| Category | Representative systems / notes |
|---|---|
| Stand-alone integrated cages (with screws) | PEEK or titanium cages with integral anterior screws/flanges, avoiding a separate plate (e.g., DePuy Synthes SynFix; NuVasive/Globus Independence; Medtronic Divergence; Centinel Spine STALIF). Common at L5-S1/L4-L5. |
| PEEK vs. titanium vs. titanium-surfaced PEEK | PEEK is radiolucent with bone-like modulus; titanium and titanium-surfaced PEEK add osteoconductive surface for on-growth. Radiodense implants may obscure intra-cage fusion assessment. |
| Category | Representative systems / notes |
|---|---|
| Anterior plate + cage constructs | A separate anterior plate with a stand-alone cage; reported with the anterior instrumentation codes when a plate spanning vertebral segments is used. |
| Large lordotic / expandable implants | Chosen to maximize disc-height and lordosis restoration; expandable devices carry higher unit cost and are a device-intensive consideration in outpatient settings. |
Supplemental fixation
ALIF may be performed stand-alone (integrated cage) or with supplemental posterior pedicle-screw instrumentation and/or posterolateral fusion for added stability (a circumferential or "360-degree" construct). Posterior fixation, when added, is reported with the posterior instrumentation codes; the need for supplemental fixation versus a stand-alone construct is a clinical judgment influenced by level, listhesis grade, and bone quality.
Bone graft & biologics - the ALIF-specific rhBMP-2 pathway
n Local / structural autograft and allograft (including structural femoral-ring allograft) and demineralized bone matrix, ceramics, and cellular bone matrices are used as graft and extenders. n rhBMP-2 (Infuse) is on-label for single-level ALIF with its specified cage via an anterior approach - a meaningful contrast with TLIF/PLIF, where posterior rhBMP-2 use is off-label. This on-label status can simplify the coverage conversation for single-level ALIF, but off-label use (multi-level, non-specified cage) remains payer-restricted and should be documented with rationale and consent. n rhBMP-2, when used, is reported on the facility/claim side with the applicable osteopromotive-material graft code; confirm the specific plan's biologic policy before the case.
FDA clearance & MRI conditionality
n Intervertebral body fusion devices are generally cleared for skeletally mature patients with degenerative disc disease at one or two levels, used with graft and (for some devices) supplemental or integral fixation; off-indication use can affect coverage. n Most contemporary titanium and PEEK constructs are labeled MR Conditional ; the specific conditions live in the manufacturer's IFU and should be captured for downstream imaging. n "Emerging" or investigational devices/techniques (for example, presacral/axial interbody approaches) are explicitly non-covered under some LCDs - confirm coverage status, not just clearance.
GOHEALTHCARE CLINICAL INSIGHTS - USE THE ON-LABEL ADVANTAGE, DON'T ASSUME IT
The on-label rhBMP-2 pathway for single-level ALIF is a genuine advantage - but it is narrow. It applies to the single-level indication with the specified device and approach; multi-level use, alternate cages, or posterior placement fall outside it. Before the case, confirm the level count, device, and the plan's biologic policy, and document informed consent. For device-intensive stand-alone or expandable implants migrating into an ASC under the 2026 rules, model the device offset and cost-per-case before shifting the site of service.
Strengthen Authorization and Revenue Integrity
GoHealthcare helps MSK specialty organizations align documentation, payer criteria, coding, scheduling, and denial-prevention workflows.
12
Policy, Evidence & Source Guidance
CMS / Medicare Coverage
There is no National Coverage Determination specific to lumbar interbody fusion. Coverage is shaped by (1) MAC LCDs and articles, (2) the OPPS/ASC payment framework and the Inpatient-Only transition, and (3) the 2-midnight rule for inpatient admission. Key points for 2026:
n LCDs. Several MACs maintain lumbar-fusion LCDs (for example, L37848 Lumbar Fusion; the earlier L33382). These generally cover fusion for documented spondylolisthesis or instability and treat fusion for isolated degenerative disc disease, or fusion added to decompression without instability, as not medically necessary. Presacral/axial interbody technique (AxiaLIF; 22586, 0195T, 0196T) and investigational devices are commonly excluded.
n Inpatient-Only phase-out includes anterior lumbar fusion. In the CY2026 OPPS/ASC Final Rule, CMS finalized eliminating the IPO list over a three-year transition beginning with musculoskeletal procedures - removing roughly 285 codes and adding hundreds of codes to the ASC Covered Procedures List. Anterior lumbar interbody fusion (22558) was included among the musculoskeletal fusion codes CMS identified for removal from the IPO list and addition to the ASC-CPL; the posterior interbody codes (22630/22633) are the most frequently cited spine examples in published summaries. Because those summaries name only selected examples, confirm 22558's final status directly in OPPS Addendum B and ASC Addendum AA at the date of service. n Site of service is now a clinical decision. Removal from the IPO list does not require outpatient performance; the surgeon documents why inpatient, hospital outpatient, or ASC is appropriate for the individual patient (comorbidities, expected recovery, safety) - a judgment reinforced for ALIF by the access-related recovery profile. n 2-midnight rule. When inpatient admission is planned, the record must support an expected stay crossing two midnights or otherwise justify inpatient status; newly removed procedures may draw medical-review attention during the transition. n Verify the status indicator. Because the transition is active, confirm the current OPPS Addendum B status indicator and the ASC payability (Addendum AA) of 22558 and the setting at the date of service.
WATCH-OUTS - THE 2026 SITE-OF-SERVICE TRAP
The IPO change is an opportunity and a liability. Commercial and Medicare Advantage plans may now steer ALIF to lower-cost sites and deny inpatient stays that are not clearly justified. Conversely, an ASC performing a newly eligible anterior fusion must confirm device-intensive payment, access-surgeon logistics, and its own clinical/vascular-safety readiness. Do not assume prior inpatient defaults still apply - re-verify per patient, per payer, per date of service.
13
Policy, Evidence & Source Guidance
Commercial Payer Comparison
Commercial and Medicare Advantage plans almost universally require prior authorization for lumbar fusion and most delegate the clinical review to a specialty utilization-management vendor. Criteria are broadly similar in structure instability or listhesis, concordant imaging, failed conservative care, risk-factor documentation - but differ in thresholds and required elements. Synthesized, not reproduced:
| Reviewer / policy | Emphasis & notable elements (verify current version) |
|---|---|
| eviCore (CMM-609 Lumbar Fusion) | Single guideline covers anterior, posterior, and combined approaches; criteria keyed to spondylolisthesis grade (Meyerding), anterolisthesis on imaging, documented instability, and failed conservative care; nicotine-free status documentation is a recurring requirement. |
| Carelon (Spine Surgery) | Degenerative spondylolisthesis with a fixed anterolisthesis or dynamic movement (on the order of 3 mm) on flexion/extension films plus symptoms/impairment not responding to at least ~6 weeks of conservative care; osteopenia/osteoporosis (DEXA T-score at or below -1.0) and implant-material allergy are cautionary/exclusionary. |
| Cohere Health | Digital intake with real-time criteria; instability, imaging correlation, and conservative-care history mirror the common framework; completeness at intake drives auto-approval. |
| Evolent / TurningPoint | MSK surgical UM programs applying comparable instability-plus-conservative-care logic; used by select regional and Medicaid plans. |
| UnitedHealthcare | Commercial spine PA plus a Medicare Advantage spine-procedures policy; requires documented instability/listhesis and neural-compression correlation. |
| Aetna (CPB 0743 / 0016) | CPB 0743 supplements LCD L37848 and requires radiologic evidence of neural compression; interbody-device policy (CPB 0016) ties device coverage to meeting the fusion criteria in CPB 0743; fusion for degenerative disc disease listed as not medically necessary. |
| Cigna (via eviCore) | Applies eviCore CMM-609 criteria; watch effective dates for version changes. |
| Humana / BCBS plans | Medicare Advantage and commercial policies (e.g., Premera 7.01.542 Lumbar Spinal Fusion in Adults) track the common instability-plus-failed-care framework. |
Common threads. Across payers: instability or listhesis (not stenosis alone) is the fusion pivot; dynamic imaging is expected when instability is claimed; a dated, structured conservative-care history is mandatory; nicotine and bone-density status are increasingly required; fusion for isolated axial back pain / degenerative disc disease is the archetypal non-covered request; and presacral/axial (AxiaLIF) techniques are commonly excluded. Always confirm which vendor holds the delegation for the specific plan and product before submitting.
14
Coverage, Documentation & Operations
Prior Authorization Workflow
A repeatable, front-loaded workflow is the difference between a first-pass approval and a cycle of information requests and peer-to-peer reviews. A representative end-to-end path:
n
- Verify benefits & delegation. Confirm the plan/product, that fusion requires PA (it almost always does), and
which UM vendor holds the review (eviCore, Carelon, Cohere, Evolent, TurningPoint) via the plan portal or NaviNet where applicable. n
- Assemble the packet. Surgeon note with the structural diagnosis and levels, correlated MRI/CT, weight-bearing
flexion/extension films, alignment films where relevant, the itemized conservative-care ledger, risk-factor documentation, and the medical-necessity statement. n
- Map to the criteria. Before submitting, walk the record against the specific vendor's criteria and fill gaps - do not
submit an incomplete packet and wait for a request for information. n
- Address the approach. Where an access/exposure surgeon will participate, confirm co-surgeon reporting
expectations and that both surgeons' roles are documented. n
- Submit & document. Submit through the required channel; record the authorization/reference number, the
criteria version, and the reviewer. n
- Manage clinical review / peer-to-peer. If a peer-to-peer is offered, prepare the surgeon with the instability or
reconstructive narrative and the conservative-care timeline. n
- Confirm site of service & codes. Ensure the authorized CPT® set matches the planned procedure (primary,
add-on levels, anterior instrumentation, interbody device, graft/biologic) and that the approved site (inpatient / HOPD / ASC) matches the plan. n
- Schedule, re-verify & close the loop to billing. Confirm the authorization is active for the scheduled date; hand
off the authorization, approved codes, co-surgeon details, and site to revenue cycle so the claim matches the authorization exactly.
15
Coverage, Documentation & Operations
Common Prior Authorization Denials
The recurring denial patterns for ALIF are predictable and therefore preventable:
n Insufficient conservative care. Duration not met, or the trial is described but not dated/itemized. n No documented instability. Fusion requested for axial pain or degenerative disc disease without listhesis, dynamic imaging, or a defined reconstructive goal. n Missing dynamic imaging. Instability claimed but no weight-bearing flexion/extension films submitted. n Imaging-symptom mismatch. Fusion level not concordant with the symptomatic level or exam. n Non-covered indication / technique. Isolated discogenic pain; presacral/axial (AxiaLIF) technique. n Unmet risk criteria. Active nicotine use or untreated osteoporosis where the policy requires otherwise. n Level, code, or approach mismatch. Authorized levels/codes or co-surgeon arrangement do not match the operative plan. n Site-of-service denial. Inpatient requested without 2-midnight support, or a setting the plan does not authorize for the code.
16
Coverage, Documentation & Operations
Appeal Strategies
Effective appeals answer the specific denial rationale with specific, dated documentation - they do not restate the original request. Practical approach:
n Read the denial reason literally and rebut that exact point (e.g., if the denial cites missing dynamic instability, lead with the flexion/extension measurements). n Supply the dated conservative-care ledger if the denial cites insufficient non-operative care. n Add the surgeon's correlation letter tying imaging to symptoms and exam and explaining why the anterior approach and fusion are indicated. n Cite the applicable policy back to the payer - show the record satisfies the plan's own criteria. n Prepare for peer-to-peer with a concise, structured summary the surgeon can deliver in under two minutes. n Escalate methodically through reconsideration and external / independent review, tracking timely-filing deadlines.
GOHEALTHCARE BEST PRACTICES - PREVENT THE PEER-TO-PEER
The most efficient appeal is the one never needed. Practices that route every fusion request through a single pre-submission checklist mapped to the specific vendor's criteria - instability or reconstructive goal documented, dynamic/alignment films attached, conservative-care ledger itemized, risk factors addressed, medical-necessity statement present, access-surgeon role clarified - convert the majority of would-be peer-to-peer reviews into first-pass approvals.
17
Coding, Billing & Revenue Integrity
Coding & Billing Overview
This is an operational coding orientation, not a reimbursement or NCCI-edit manual; detailed payment methodology belongs to the GoHealthcare Revenue Cycle Knowledge Center. Key principles for ALIF:
n ALIF is reported with the anterior interbody arthrodesis code 22558 (single interspace, lumbar); +22585 is added for each additional interspace. n The minimal discectomy intrinsic to interspace preparation is included in the arthrodesis and is not separately reported as a decompression. n The interbody device (+22853) and bone graft are reported with their own add-on codes, each supported by the operative note. n Anterior instrumentation is reported with 22845 (2-3 vertebral segments), 22846 (4-7), or 22847 (8+). When ALIF is combined with posterior instrumentation for a circumferential construct, the posterior instrumentation codes (e.g., 22840 non-segmental, 22842 segmental) apply instead/in addition, per the operative note. n When an access/exposure surgeon and the spine surgeon act as co-surgeons throughout, modifier 62 may apply to the primary and add-on arthrodesis codes, with each surgeon dictating a distinct operative note. n The same 22558 code also describes lateral (XLIF/LLIF) and oblique (OLIF) interbody approaches; the approach is documented in the note, not distinguished by a different arthrodesis code. n Place of service and ASC eligibility shifted for 2026 (see CMS section); the claim's site must match the authorization.
18
Coding, Billing & Revenue Integrity
Applicable CPT Codes
| Code | Descriptor (abbreviated) | Role in ALIF |
|---|---|---|
| 22558 | Arthrodesis, anterior interbody technique, incl. minimal discectomy to prepare interspace (other than for decompression); lumbar | Primary ALIF code (also XLIF/OLIF) |
| +22585 | Each additional interspace; lumbar | Add-on for each additional level |
| Code | Descriptor (abbreviated) | Role in ALIF |
|---|---|---|
| +22853 | Insertion of interbody biomechanical device (e.g., cage/mesh) in conjunction with interbody arthrodesis, each interspace | Interbody spacer add-on |
| +22845 | Anterior instrumentation; 2-3 vertebral segments | Anterior plate/construct add-on |
| +22846 / +22847 | Anterior instrumentation; 4-7 / 8+ vertebral segments | Longer anterior constructs |
| +22840 / +22842 | Posterior non-segmental / segmental (3-6 segments) instrumentation | When ALIF is combined with posterior fixation (360-degree) |
| +20936 / +20937 / +20938 / 20930 / 20931 | Autograft (local / separate incision / structural) / allograft (morselized / structural) | Bone graft add-on codes |
Codes are listed for operational orientation and must be verified against the current CPT® code set, payer policy, and NCCI edits before submission. Add-on codes are reported in addition to the primary procedure and are exempt from modifier 51. 22586 (presacral/AxiaLIF) is a distinct, commonly non-covered technique - do not use it to report a standard open ALIF.
19
Coverage, Documentation & Operations
HCPCS Codes (When Applicable)
For most physician (professional) claims, ALIF is captured by the CPT® set above and there is no separate physician HCPCS code for the implant. HCPCS Level II codes may appear on the facility side (hospital outpatient / ASC) for device and biologic reporting, and pass-through or device-category C-codes may apply to specific implants (including the osteopromotive-material code used to report rhBMP-2) in the OPPS/ASC setting. Because device coding is setting- and date-specific, confirm the current facility HCPCS/C-code and any device-intensive designation with the facility's chargemaster and the payer at the date of service.
20
Coding, Billing & Revenue Integrity
Common ICD-10-CM Diagnosis Codes
Diagnosis selection must be specific to region and to the documented clinical detail. The codes below are frequently applicable to ALIF indications and were confirmed as billable for the current fiscal year (valid through 09/30/2026); always code to the documentation.
| ICD-10-CM | Description | Note |
|---|---|---|
| M43.16 | Spondylolisthesis, lumbar region | Billable |
| M43.17 | Spondylolisthesis, lumbosacral region | Billable (common at L5-S1) |
| M48.061 | Spinal stenosis, lumbar region, without neurogenic claudication | Billable; parent M48.06 is NOT billable |
| M48.062 | Spinal stenosis, lumbar region, with neurogenic claudication | Requires documented claudication, not imaging alone |
| M48.07 | Spinal stenosis, lumbosacral region | Use lumbosacral series when applicable |
| M51.16 | Intervertebral disc disorder with radiculopathy, lumbar region | Billable |
| M51.17 | Intervertebral disc disorder with radiculopathy, lumbosacral region | Billable |
| M51.26 | Other intervertebral disc displacement, lumbar region | Herniation without myelopathy/radiculopathy |
| M51.36 | Other intervertebral disc degeneration, lumbar region | DDD alone rarely supports fusion |
| M53.2X6 / M53.2X7 | Spinal instabilities, lumbar / lumbosacral region | Code to the documented site of instability |
| ICD-10-CM | Description | Note |
|---|---|---|
| M96.0 | Pseudarthrosis after arthrodesis or fusion | Failed prior fusion (revision context) |
| M43.06 | Spondylolysis, lumbar region | Pars defect (isthmic context) |
Avoid non-billable parent codes (for example, M48.06 for lumbar stenosis requires the 5th/6th-character specificity of M48.061 or M48.062). Match the region (lumbar vs. lumbosacral) to the operative level; L5-S1 ALIF frequently uses the lumbosacral-region codes.
21
Coding, Billing & Revenue Integrity
Applicable Modifiers
| Modifier | Use in the ALIF context |
|---|---|
| -62 | Two surgeons (co-surgeons) - the common ALIF scenario where an access/exposure surgeon and the spine surgeon each perform a distinct part of the procedure and each dictates an operative note; may apply to 22558 and +22585. |
| -51 | Multiple procedures (note add-on codes are exempt from -51). |
| -59 / X{EPSU} | Distinct procedural service - e.g., a separately reportable service at a different level; use the most specific X modifier where required. |
| -22 | Increased procedural services - only with explicit documentation of substantially greater work; typically applied to the primary code. |
| -80 / -82 | Assistant surgeon / assistant when a qualified resident is unavailable, per payer rules. |
| -58 / -78 / -79 | Staged/related/unrelated procedure during the global period, as applicable to staged 360-degree or revision procedures. |
22
Coverage, Documentation & Operations
Clinical Documentation Checklist
A consolidated, pre-submission checklist for the authorization packet and the operative-note handoff to coding:
n Structural diagnosis with level(s) and, for listhesis, Meyerding grade n Concordant symptom description (axial vs. radicular vs. claudicant) with duration n Neurological examination findings n MRI/CT correlated to the symptomatic level n Weight-bearing flexion/extension radiographs for instability-based requests n Standing / sagittal-alignment films where lordosis restoration is a goal n Itemized, dated conservative-care ledger with measured response n Nicotine status + cessation counseling; bone-density status where relevant n Rationale for the anterior approach; retrograde-ejaculation counseling (males) where applicable n Access/exposure-surgeon role documented for co-surgery reporting n Planned levels, standalone vs. supplemental fixation, interbody device, graft/biologic (incl. rhBMP-2 rationale/consent if used) n Explicit surgeon medical-necessity statement and site-of-service rationale n Authorization number, criteria version, and approved code set on file
23
Coverage, Documentation & Operations
Procedure Comparison (When Applicable)
ALIF is one of several interbody approaches. The comparison below is operational, not a surgical selection guide; approach choice is the surgeon's clinical decision.
| Approach | Corridor / access | Operational notes |
| ALIF | Anterior retroperitoneal / transperitoneal | Code 22558; best disc-height/lordosis restoration; access-surgeon & great-vessel considerations; on-label rhBMP-2 (single level) |
| TLIF | Posterior, transforaminal | Combined code 22633; single-side interbody; posterior rhBMP-2 is off-label |
| PLIF | Posterior, bilateral to disc | Straight interbody = 22630; more neural retraction |
| XLIF / LLIF | Lateral transpsoas | Also coded 22558; neuromonitoring emphasis |
| OLIF | Anterolateral (oblique, pre-psoas) | Also coded 22558; corridor differs from XLIF |
| Decompression alone | Posterior, no fusion | Preferred when no instability; the payer-favored alternative in select degenerative spondylolisthesis |
TLIF, PLIF, XLIF, OLIF, and revision lumbar fusion are addressed in their own guides in the GoHealthcare MSK Specialty Procedure Library™.
24
GoHealthcare Operational Guidance
GoHealthcare Clinical Insights
Document both stories. Every ALIF record needs the medical-necessity story (why fuse) and the approach story (who exposed and how the corridor was managed). Missing the second creates co-surgery friction.
Name the reconstructive goal. Where lordosis or sagittal-alignment restoration is the rationale, state it explicitly with the alignment films - it is a defensible, ALIF-specific necessity argument.
Use the on-label biologic advantage precisely. Single-level ALIF with the specified cage is the on-label rhBMP-2 window; confirm level count and device before assuming it.
Match the claim to the authorization. Levels, anterior vs. posterior instrumentation, co-surgeon arrangement, and site of service must align exactly.
25
GoHealthcare Operational Guidance
GoHealthcare Leadership Perspective
ALIF sits where the highest clinical stakes meet the highest administrative complexity in musculoskeletal care, and 2026 raised both. The elimination of the Inpatient-Only list for musculoskeletal procedures moved anterior lumbar interbody fusion into a world where site of service is a documented clinical judgment rather than a default expanding ASC opportunity while inviting payers to challenge inpatient stays and requiring centers to build vascular-safety and access-surgeon capabilities before migrating cases.
The durable operational advantage is a disciplined, criteria-mapped intake process that also captures ALIF's distinctive elements: the anterior-approach rationale, the access-surgeon role, and the on-label biologic pathway. The same discipline that prevents denials - instability or reconstructive goal documented, dynamic and alignment imaging attached, conservative care itemized, approach and co-surgery clarified, site of service justified - also protects the organization on compliance and supports clean, auditable revenue. AI-enabled intake and criteria-matching tools accelerate this, but they amplify a sound process rather than replace the clinical judgment and documentation that anchor medical necessity.
26
GoHealthcare Operational Guidance
GoHealthcare Prior Authorization Insight
Know the delegation before you write a word. Confirm whether eviCore, Carelon, Cohere, Evolent, or TurningPoint holds the review, then write to that vendor's criteria version.
Pre-empt the peer-to-peer. The elements that trigger a P2P are knowable in advance: missing dynamic films, an unquantified conservative-care history, an ambiguous fusion-versus-decompression rationale. Close those gaps at intake.
Quantify everything. "Chronic pain, failed conservative treatment" is not reviewable. "12 weeks of PT, two injections with dated partial relief, ODI 46, grade 1 anterolisthesis with 4 mm translation at L5-S1, planned for lordosis restoration" is.
Resolve the approach coding up front. Clarify the access-surgeon / co-surgeon arrangement and confirm anterior versus combined (360-degree) instrumentation before the case so the authorization, operative note, and claim all agree.
27
GoHealthcare Operational Guidance
GoHealthcare Case Study
Clinical scenario. A patient in the fifth decade presents with mechanical low back pain and right S1 radicular symptoms, with a grade 1 isthmic spondylolisthesis at L5-S1 and collapsed disc height.
Documentation challenges. The initial authorization packet led with pain severity, attached only supine MRI, described conservative care as "PT and injections" without dates, and did not state why an anterior approach was chosen.
Prior authorization barriers. The delegated vendor pended the request citing (1) no dynamic imaging to establish instability and (2) an unquantified conservative-care history, and offered a peer-to-peer.
Payer considerations. The plan's criteria required a fixed or dynamic anterolisthesis on weight-bearing films plus a defined, failed conservative-care course; the interbody-device policy tied cage coverage to meeting the fusion criteria.
Operational workflow. The authorization lead obtained standing flexion/extension films (confirming translation at L5-S1), reconstructed a dated conservative-care ledger (12 weeks of supervised PT and two transforaminal ESIs with documented transient relief), added a surgeon letter explaining the anterior approach for disc-height and lordosis restoration with indirect foraminal decompression, and clarified the access-surgeon / co-surgeon arrangement.
Resolution strategy. The rebuilt packet was resubmitted mapped line-by-line to the vendor's criteria, with the surgeon briefed for a two-minute peer-to-peer focused on the instability finding and reconstructive goal.
Outcome. The request was approved without a formal denial; the scheduled CPT® set (22558, interbody device, single-level on-label rhBMP-2, and the co-surgeon arrangement) and site of service matched the authorization, and the claim adjudicated cleanly.
Lessons learned. The instability and the reconstructive rationale existed all along; the case turned on documenting them with the right imaging, a quantified conservative-care history, an explicit anterior-approach rationale, and a clarified co-surgeon arrangement.
28
GoHealthcare Operational Guidance
GoHealthcare Best Practices
n Adopt a single pre-submission fusion checklist mapped to each major vendor's criteria; make it mandatory intake. n Capture weight-bearing flexion/extension films (and alignment films where relevant) at the visit - do not wait for a pend. n State the anterior-approach rationale and, where used, the on-label rhBMP-2 basis and consent. n Clarify the access-surgeon / co-surgeon arrangement before the case and document each surgeon's distinct role. n Maintain a dated conservative-care ledger template in the EHR so the history is itemized by default. n Run a two-role QA (coder + clinical reviewer) before submission and again before the claim drops. n Re-verify site-of-service eligibility (Addendum AA/B) per patient/payer/date given the 2026 IPO transition. n Reconcile the operative note against the authorized code set so anterior vs. posterior instrumentation and every add-on is supported.
29
Coverage, Documentation & Operations
Common Mistakes
n Coding a standard open ALIF with the presacral/axial code 22586 (a distinct, commonly non-covered technique).
n Reporting posterior instrumentation codes for an anterior-only construct (use 22845-22847 for anterior instrumentation). n Omitting or mis-applying the co-surgeon modifier 62 when an access surgeon participated. n Submitting instability requests with supine imaging only. n Describing conservative care without dates, providers, or measured response. n Using non-billable parent ICD-10 codes (e.g., M48.06) or region-mismatched codes at L5-S1. n Assuming rhBMP-2 is on-label beyond the single-level ALIF indication, or skipping the biologic-policy check. n Assuming prior inpatient defaults still apply after the 2026 IPO changes.
30
GoHealthcare Operational Guidance
Pearls and Pitfalls
Pearls
n Instability or a defined reconstructive goal - not stenosis alone - is the fusion pivot; document it explicitly. n Two imaging jobs: static (pathology) and dynamic (instability); add alignment films when lordosis restoration is the rationale. n Single-level ALIF is the on-label rhBMP-2 window - a genuine, if narrow, advantage. n Clarify co-surgery and anterior-vs-360 instrumentation before the case to keep authorization, note, and claim aligned.
Pitfalls
n Discography-only justification is disfavored by most current policies. n Presacral/axial (AxiaLIF) technique is commonly non-covered/investigational. n Great-vessel and retrograde-ejaculation risks are ALIF-specific and belong in consent. n Site-of-service assumptions carried over from pre-2026 practice.
31
Coverage, Documentation & Operations
Frequently Asked Questions
What is the primary CPT® code for a single-level lumbar ALIF?
22558 (anterior interbody arthrodesis, single lumbar interspace); +22585 is added for each additional interspace.
Is ALIF coded differently from TLIF or PLIF?
Yes. ALIF uses the anterior interbody code 22558; TLIF uses the combined posterior/posterolateral code 22633; straight PLIF uses 22630. The approach documented in the operative note drives the code.
Does 22558 also cover XLIF and OLIF?
Yes. Per NASS coding guidance, the anterior/anterolateral arthrodesis code 22558 is used for lateral (XLIF/LLIF) and oblique (OLIF) interbody fusions as well; the specific corridor is documented in the note.
How is the interbody cage coded?
With the interbody biomechanical device add-on +22853 (device inserted in conjunction with interbody arthrodesis), reported per interspace.
How is anterior instrumentation coded?
With the anterior instrumentation codes: 22845 (2-3 vertebral segments), 22846 (4-7), or 22847 (8+). If the ALIF is combined with posterior fixation for a 360-degree construct, the posterior instrumentation codes apply instead/in addition.
What is the co-surgeon modifier and when does it apply to ALIF?
Modifier 62. When an access/exposure surgeon and the spine surgeon act as co-primary surgeons for the procedure, each performing a distinct part and dictating a separate operative note, modifier 62 may be appended to the primary and add-on arthrodesis codes.
Does Medicare have an NCD for lumbar fusion?
No. Coverage is governed by MAC LCDs/articles, the OPPS/ASC framework, the Inpatient-Only transition, and the 2-midnight rule rather than a national determination.
Did ALIF move off the Medicare Inpatient-Only list for 2026?
As part of the CY2026 IPO phase-out, which began with musculoskeletal procedures, CMS identified anterior lumbar interbody fusion (22558) among the fusion codes for removal from the IPO list and addition to the ASC Covered Procedures List. Published summaries most often cite the posterior codes (22630/22633) as spine examples, so confirm 22558's final status in OPPS Addendum B / ASC Addendum AA at the date of service before relying on outpatient or ASC performance.
Does that mean ALIF must now be done in an ASC?
No. Removal from the IPO list makes outpatient and ASC performance possible when appropriate; it does not mandate it. The surgeon documents the clinical rationale for the chosen site, and the ASC must have the vascular-safety and access capability.
Is rhBMP-2 (Infuse) on-label for ALIF?
Yes for single-level ALIF with its specified cage via an anterior approach - this is the on-label indication, in contrast to TLIF/PLIF where posterior use is off-label. Multi-level or non-specified-device use remains off-label and payer-restricted.
Which utilization-management vendors review lumbar fusion?
Commonly eviCore (CMM-609), Carelon, Cohere, Evolent, and TurningPoint, depending on the plan and product. Confirm the delegation before submitting.
How much conservative care is required before approval?
It varies - often a minimum of about 6 weeks for a clearly unstable, symptomatic listhesis, and commonly 3-6 months otherwise. The record must show structured, dated, failed care.
What imaging do payers expect?
MRI or CT establishing the pathology, plus weight-bearing flexion/extension radiographs when instability is the indication, and standing/alignment films when lordosis restoration is a goal.
Why do payers focus so much on instability?
Because the evidence base supports fusion primarily where instability is present; stenosis or axial pain alone often responds to decompression alone, so instability (or a defined reconstructive goal) is the criterion that distinguishes a fusion candidate.
Is fusion for degenerative disc disease covered?
Isolated degenerative disc disease / discogenic axial pain without instability, listhesis, or a defined reconstructive goal is the classic payer-scrutinized indication across CMS-aligned LCDs and most commercial policies.
What ICD-10 code is used for L5-S1 spondylolisthesis?
M43.17 for the lumbosacral region (M43.16 for the lumbar region); code to the documented level.
Why can't I use M48.06 for lumbar stenosis?
M48.06 is a non-billable parent; use M48.061 (without neurogenic claudication) or M48.062 (with neurogenic claudication), documenting claudication clinically if using M48.062.
Is AxiaLIF / presacral fusion the same as ALIF?
No. Presacral/axial interbody fusion (AxiaLIF; CPT 22586, 0195T, 0196T) is a distinct technique that is commonly non-covered or investigational under LCDs; do not report a standard open ALIF with 22586.
What are the ALIF-specific risks patients should be counseled on?
Great-vessel injury from the anterior approach and, in males, retrograde ejaculation from superior hypogastric plexus disruption; these belong in the consent and, where relevant, the record.
What are the most common denial reasons?
Insufficient/undated conservative care, no documented instability, missing dynamic imaging, imaging-symptom mismatch, non-covered indication/technique, unmet nicotine/bone-density criteria, and code/approach/site mismatches.
How do I prevent a peer-to-peer review?
Front-load the packet against the specific vendor's criteria: instability or reconstructive goal documented, dynamic/alignment films attached, conservative care itemized, risk factors addressed, approach and co-surgery clarified, and a surgeon medical-necessity statement included.
How should site of service be documented in 2026?
State the clinical rationale for inpatient, hospital outpatient, or ASC based on comorbidities, expected recovery (including the anterior-approach profile), and safety, and ensure the authorized site matches the claim; re-verify per payer and date of service.
32
Coverage, Documentation & Operations
Key Takeaways
n ALIF is reported with the anterior interbody code 22558 (+22585 per additional level); the same code also describes XLIF and OLIF. n Anterior instrumentation uses 22845-22847; a combined 360-degree construct adds the posterior instrumentation codes. Co-surgeon modifier 62 commonly applies when an access surgeon participates. n Instability, listhesis, or a defined reconstructive (lordosis/alignment) goal - not stenosis or axial pain alone - is the pivot on which fusion coverage turns. n Instability-based requests require weight-bearing flexion/extension imaging; add alignment films when lordosis restoration is the rationale. n rhBMP-2 (Infuse) is on-label for single-level ALIF with its specified cage - a genuine, narrow advantage over posterior interbody fusions. n For CY2026, CMS's IPO phase-out (musculoskeletal-first) moved anterior lumbar interbody fusion (22558) toward outpatient/ASC eligibility; site of service is now a documented clinical decision - confirm 22558's final OPPS Addendum B / ASC Addendum AA status at the date of service. n Presacral/axial (AxiaLIF; 22586) is a distinct, commonly non-covered technique - do not use it to report a standard open ALIF.
33
Coverage, Documentation & Operations
Future Outlook
Several trends will shape ALIF operations over the coming cycles:
n Site-of-service migration. With the Inpatient-Only list phasing out and 22558 now ASC-eligible, expect selected anterior fusions to move toward hospital outpatient and ASC settings - contingent on vascular-safety readiness, access-surgeon logistics, and device-intensive payment modeling.
n Stand-alone construct evolution. Integrated cages with titanium surfaces continue to reduce reliance on supplemental posterior fixation for selected single-level cases, with implications for operative time, cost, and site of service. n Evidence-driven criteria. Instability documentation will remain the decisive coverage element; reconstructive/alignment indications will require explicit sagittal-parameter documentation. n Enabling technology. Navigation, robotics, and enhanced anterior-access techniques are expanding, with implications for planning and outcomes tracking rather than for the core arthrodesis code. n AI-enabled authorization. Payer-side automated review and provider-side criteria-matching tools will accelerate adjudication; the advantage accrues to practices whose underlying documentation is already complete and criteria-mapped.
34
Policy, Evidence & Source Guidance
References
Authoritative sources; verify the current version and effective date of each before relying on it. URLs were active at the time of authorship.
- Centers for Medicare & Medicaid Services. Medicare Coverage Database (NCDs, LCDs, Articles).
https://www.cms.gov/medicare-coverage-database
- CMS. CY2026 Hospital OPPS and Ambulatory Surgical Center Payment System Final Rule (Inpatient-Only list phase-out; ASC
Covered Procedures List, Addendum AA). https://www.cms.gov/medicare/payment/prospective-payment-systems/hospital-outpatient
- CMS. Medicare Learning Network - OPPS/ASC and status-indicator resources. https://www.cms.gov/medicare/coding-billing
- LCD L37848, Lumbar Spinal Fusion (representative MAC LCD).
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37848
- LCD L33382, Lumbar Spinal Fusion for Instability and Degenerative Disc Conditions.
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33382
- eviCore by Evernorth. CMM-609: Lumbar Fusion (Arthrodesis) clinical guidelines.
https://www.evicore.com/provider/clinical-guidelines
- Carelon Medical Benefits Management. Spine Surgery Clinical Appropriateness Guidelines.
https://guidelines.carelonmedicalbenefitsmanagement.com
- Aetna. Clinical Policy Bulletin 0743, Spinal Surgery: Laminectomy and Fusion; CPB 0016, Interbody Fusion Devices.
https://www.aetna.com/cpb/medical/data/700_799/0743.html
- UnitedHealthcare. Spine Procedures medical policies (commercial and Medicare Advantage). https://www.uhcprovider.com
- Premera Blue Cross. Medical Policy 7.01.542, Lumbar Spinal Fusion in Adults.
https://www.premera.com/medicalpolicies/7.01.542.pdf
- North American Spine Society (NASS). Coverage Policy Recommendations - Lumbar Fusion; coding guidance for interbody
fusion. https://www.spine.org
- American Association of Neurological Surgeons / Congress of Neurological Surgeons. Guideline update for fusion procedures for
degenerative lumbar spine disease, including Part 11 (interbody techniques). https://www.cns.org
- Ghogawala Z, et al. Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis (SLIP). N Engl J Med.
2016;374(15):1424-1434. https://www.nejm.org
- Forsth P, et al. A randomized, controlled trial of fusion surgery for lumbar spinal stenosis. N Engl J Med. 2016;374(15):1413-1423.
- Austevoll IM, et al. Decompression with or without fusion in degenerative lumbar spondylolisthesis (NORDSTEN-DS). N Engl J Med.
2021;385(6):526-538. https://www.nejm.org
- U.S. Food & Drug Administration. Intervertebral body fusion device clearances and rhBMP-2 (Infuse) approval/labeling for anterior
lumbar interbody fusion. https://www.fda.gov
- American Medical Association. CPT® code set (current year). https://www.ama-assn.org/practice-management/cpt
Build a Defensible, Scalable Procedure Workflow
GoHealthcare supports prior authorization, medical-necessity documentation, payer policy interpretation, coding and revenue integrity, appeals, and MSK specialty workflow design.
Developed By
Pinky Maniri
MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare A.I. Governance
Founder and Chief Executive Officer, GoHealthcare Practice Solutions
Educational and Operational Disclaimer
This content is provided for educational and operational planning purposes and is not medical, legal, coding, reimbursement, or payer-contract advice. Coverage, authorization, coding, payment, and clinical requirements vary by patient, plan, product, jurisdiction, Medicare Administrative Contractor, date of service, setting, and current policy. Verify the controlling source before scheduling, authorization, billing, appeal, or clinical decision-making. Authorization does not guarantee coverage or payment.